Market Introduction This research report provides insights into the Middle East & Africa Medical Devices market.A medical device can be a machine, instrument, apparatus, an article that is used to diagnose, monitor, and therapeutic purposes.
A medical device plays an essential role, such as detection, measurement, restoration, and modification of the structure or a function of the body due to health problems or chronic medical conditions. There are various types of medical devices, which include glasses, pacemakers, wheelchairs, X-ray machines, MRI, CT scans, and many more.
Market Overview and Dynamics The Middle East & Africa Medical Devices is expected to reach US$ 21,802.3 million in 2027 from US$ 16,597.4 million in 2019; it is estimated to grow at a CAGR of 3.6% from 2020 to 2027. The Middle East & Africa region is witnessing significant growth in its healthcare sector. Middle East & Africa consists of three major countries namely United Arab Emirates (UAE), Saudi Arabia and South Africa. The market is driven by the factors such as increasing government initiatives, growing number of research and development activities, and increasing number of market players in the region. The government of Saudi Arabia is promoting and offering several incentives for domestic manufacturing for the medical devices, which in turn can drive the overall market growth in this country. In December 2019, Saudi Arabia’s Food and Drug Authority launched a single platform to submit and authorize new medical applications. This single platform enables a single point of contact to deal with stringent regulations and guidelines, which will eventually increase the number of medical devices introductions in the market, leading to Saudi Arabia medical devices market growth. Further, the government and other organizations conduct conferences, symposiums, and meetings to educate the population and spread awareness about the technologically advanced and high standard medical device available in the market. For instance, the country organized a meeting on Parkinson’s Disease and Other Movement Disorders in Jeddah in April 2019. After the success of this meeting, in November 2020, the 3rd Saudi Movement Disorders Conference will be held In Jeddah to focus on more therapies in the treatment of Parkinson’s disease and other movement disorders. These constructive factors are projected to drive the Saudi Arabia medical devices market during the forecast period.
Key Market Segments In terms of product type, the In Vitro Diagnostics (IVD) segment held the largest share of the market in 2019; However, neurology devices is estimated to register the highest CAGR of 8.8% in the market during the forecast period. The growing hospital incidences of hospital acquired infections and new developments by the market players is likely to drive the market growth. In terms of function, the Diagnostic and Monitoring segment held a larger share of the market in 2019 and surgical segment is estimated to register a higher market share in the market during the forecast period. In terms of end use, the hospital segment held a larger share of the market in 2019 and also is estimated to register a higher market share in the market during the forecast period.
Major Sources and Companies Listed The World Health Organization (WHO), Food and Drug Administration (FDA), are some of the major primary and secondary sources for the Middle East & Africa Medical Devices market included in the report.
Middle East & Africa Medical Devices Market Segmentation By Product Type • In Vitro Diagnostics (IVD) • Surgical Device o Minimally invasive surgery instruments o Electrosurgical Generators o Ultrasonic Surgical Generators o Others • General Medical devices • Cardivascular devices • Orthopedic • Infection control devices • Ophthalmology • Endoscopy • Neurology • Others
By Function • Diagnostic and Monitoring • Surgical • Therapeutics • Others
By End Use • Hospital • Ambulatory Care • Homecare • Others
Company Profiles • Medtronic • Abbott • Boston Scientific Corporation • Braun Melsungen AG • 3M • General Electric Company • Stryker Corporation • Koninklijke Philips N.V. • Siemens AG; • Johnson and Johnson Services, Inc.
Our reports have been used by over 10K customers, including:
The Middle East & Africa organoids market is expected to reach US$ 141.26 million in 2027 from US$ 37.34 million in 2019; the market is estimated to grow at a CAGR of 20.9% from 2020 to 2027. The growth of the market can be attributed to growing research on organoids in the Middle East & Africa region and rising focus on developing alternatives...
The Asia Pacific organoids market is expected to reach US$ 513.74 million in 2027 from US$ 97.02 million in 2019. The market is estimated to grow at a CAGR of 23.1% from 2020 to 2027. Rising adoption of biobanking and tumor modelling and alternatives for animal testing models acting as kingpins are expected to augment the growth of the...
The global organoids market is expected to reach US$ 3,420.40 million by 2027 from US$ 689.47 million in 2019. The market is estimated to grow at a CAGR of 22.1% from 2020 to 2027. Increasing demand for tumor modelling and biobanking, rising adoption of personalized drugs, and growing focus on developing alternatives for animal testing...
The Europe organoids market is projected to reach US$ 1,260.08 million by 2027 from US$ 247.85 million in 2019; it is estimated to grow at a CAGR of 22.5% from 2020 to 2027. Increasing demand for tumor modelling and biobanking and rising adoption of personalized drugs are expected to drive the market. Personalized medicine is a growing...
The North America organoids market is expected to reach US$ 1,406.47 million by 2027 from US$ 291.39 million in 2019. The market is anticipated to grow at a CAGR of 21.7% from 2020 to 2027. Growth of the North America organoids market is attributed to emergence of three-dimensional (3D) organoids and rise in investments in research. However,...
The South and Central America nurse call systems market is expected to reach US$ 200.11 million by 2027 from US$ 87.23 million in 2019. The market is estimated to grow at a CAGR of 10.8% from 2020-2027. The growth of the South and Central America nurse call systems market is driven by the growing incidence of Alzheimer’s disease and dementia...
The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period. The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected...
The global human microbiome market is expected to reach US$ 1,873.53 million by 2027 from US$ 356.29 million in 2019. The market is estimated to grow with a CAGR of 23.6% from 2020 to 2027. The growth of the market is driven by the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies,...
Healthy future: Despite the mounting likelihood of new regulation, industry revenue will likely grow Abstract Cryogenic Biobanking Services Since the landmark scientific achievement of human genome sequencing in 2003, the Cryogenic Biobanking Services industry is increasingly viewed as the link between...
Step by step: An aging US population and a rising prevalence of diabetes are expected to boost industry demand Abstract Podiatrists in the US Over the five years to 2019, the Podiatrists industry has stepped in the right direction. Revenue growth has been supported by the aging US population and the...
Healthcare
Health Care Provider
Health Services
Pathology
Infectious Disease
United States
Health Provider Density
Employment Income
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.